Blog | Ningbo Fine Chemicals Co.,Ltd

Ningbo Fine Chemicals Co.,Ltd

Jul 21, 2023

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Concurrent Chemoradiotherapy as Treatment for Patients With Newly Diagnosed High September 20, 2023 6:45 am ET Acceptance based on results from the Phase 3 KEYNOTE-A18 trial, which showed a statistical view more
Jul 19, 2023

An Overview Of Sex Hormones Suja Sukamaran, Sudhir Dahal, Eden Couillard, Mike Garry In this interview, Thermo Fisher Scientific discusses how to en view more
Jul 17, 2023

A comprehensive analysis of the role of QPRT in breast cancer Scientific Reports volume 13, Article number: 15414 (2023) Cite this article 428 Accesses 1 Altmetric Metrics details To view more

1 2 3 4 5

LATEST NEWS